The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7

The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7

Abstract Atherosclerosis is one of the leading causes of death worldwide. miR-26 is a potential biomarker of atherosclerosis. Standardized diagnostic tests for miR-26 (MIR26-DX) have been developed, but the fastest progress has been in predicting the efficacy of IFN-α therapy for hepatocellular carc...

Full description

Bibliographic Details
Main Authors: Wujun Chen, Xiaolin Wu, Jianxia Hu, Xiaolei Liu, Zhu Guo, Jianfeng Wu, Yingchun Shao, Minglu Hao, Shuangshuang Zhang, Weichao Hu, Yanhong Wang, Miao Zhang, Meng Zhu, Chao Wang, Yudong Wu, Jie Wang, Dongming Xing
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Cardiovascular Diabetology
Subjects:
miR-26
IFN-α therapy
COL1A1
FBP1
DGAT2
SMAD7
Online Access:https://doi.org/10.1186/s12933-024-02119-z

Internet

https://doi.org/10.1186/s12933-024-02119-z

Similar Items